US 11028048
Heterocyclic compound and use thereof
granted A61KA61K31/40A61K31/4025
Quick answer
US patent 11028048 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/40, A61K31/4025, A61K31/422, A61K31/427